Case Reports
doi: 10.1093/jnci/84.4.264.
Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results
Affiliations
- PMID: 1734088
- DOI: 10.1093/jnci/84.4.264
Item in Clipboard
Case Reports
Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results
J Natl Cancer Inst.
.
No abstract available
Comment in
-
Depletion of glutathione in normal and malignant human cells in vivo by L-buthionine sulfoximine: possible interaction with ascorbate.J Natl Cancer Inst. 1992 Oct 21;84(20):1601-2. doi: 10.1093/jnci/84.20.1601-a. J Natl Cancer Inst. 1992. PMID: 1285780 No abstract available.
Similar articles
-
Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.J Clin Oncol. 1994 Jan;12(1):194-205. doi: 10.1200/JCO.1994.12.1.194. J Clin Oncol. 1994. PMID: 8270977 Clinical Trial.
-
Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.J Clin Oncol. 1996 Jan;14(1):249-56. doi: 10.1200/JCO.1996.14.1.249. J Clin Oncol. 1996. PMID: 8558205 Clinical Trial.
-
Time-dependent pharmacodynamic models in cancer chemotherapy: population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine (BSO) in a Phase I trial of melphalan and BSO.Cancer Res. 1995 Oct 15;55(20):4507-11. Cancer Res. 1995. PMID: 7553617 Clinical Trial.
-
The role of glutathione in drug resistance.Cancer Treat Rev. 1990 Dec;17 Suppl A:45-50. doi: 10.1016/0305-7372(90)90015-8. Cancer Treat Rev. 1990. PMID: 2092870 Review. No abstract available.
-
Non-chemotherapeutic agents that potentiate chemotherapy efficacy.Cancer Treat Rev. 1989 Mar;16(1):1-40. doi: 10.1016/0305-7372(89)90002-9. Cancer Treat Rev. 1989. PMID: 2659168 Review. No abstract available.
Cited by
-
Redox-Related Proteins in Melanoma Progression.Antioxidants (Basel). 2022 Feb 22;11(3):438. doi: 10.3390/antiox11030438. Antioxidants (Basel). 2022. PMID: 35326089 Free PMC article.
-
Evidence for glutathione involvement in platelet-derived growth-factor-mediated signal transduction.Biochem J. 1997 Jun 15;324 ( Pt 3)(Pt 3):791-6. doi: 10.1042/bj3240791. Biochem J. 1997. PMID: 9210402 Free PMC article.
-
Altered glutathione metabolism in the tumor-bearing state.Ann Surg Oncol. 1995 Jul;2(4):332-5. doi: 10.1007/BF02307066. Ann Surg Oncol. 1995. PMID: 7552623
-
Development of Telintra as an Inhibitor of Glutathione S-Transferase P.Handb Exp Pharmacol. 2021;264:71-91. doi: 10.1007/164_2020_392. Handb Exp Pharmacol. 2021. PMID: 32767141 Free PMC article.
-
Isolated limb infusion as a model to test new agents to treat metastatic melanoma.J Surg Oncol. 2014 Mar;109(4):357-65. doi: 10.1002/jso.23502. Epub 2013 Nov 20. J Surg Oncol. 2014. PMID: 24522940 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
